Keyphrases
In-hospital Mortality
100%
α1-adrenoceptor Antagonist
100%
COVID-19
100%
Odds Ratio
50%
Relative Risk Reduction
50%
Doxazosin
33%
Admission Time
33%
Hospitalization
16%
Etiology
16%
Randomized Placebo-controlled Trial
16%
Prazosin
16%
Asymptomatic Infection
16%
Preclinical Data
16%
Effective Therapy
16%
Reduced Mortality
16%
Terazosin
16%
Negative Association
16%
Department of Veterans Affairs
16%
Tamsulosin
16%
Retrospective Cohort Design
16%
α1-adrenergic Receptor
16%
Hyperinflammation
16%
Doubly Robust Methods
16%
Veterans Affairs Healthcare System
16%
Silodosin
16%
Robust Matching
16%
Robust Regression
16%
Alfuzosin
16%
Medicine and Dentistry
Hospital Mortality
100%
Alpha 1 Adrenergic Receptor Blocking Agent
100%
COVID-19
100%
Odds Ratio
50%
Relative Risk Reduction
50%
Doxazosin
33%
Infection
16%
Placebo
16%
Controlled Clinical Trial
16%
Veterans Affairs
16%
Tamsulosin
16%
Terazosin
16%
Prazosin
16%
Alpha 1 Adrenergic Receptor
16%
Silodosin
16%
Alfuzosin
16%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Hospital Mortality
100%
Alpha 1 Adrenergic Receptor Blocking Agent
100%
Coronavirinae
100%
Doxazosin
33%
Placebo
16%
Infection
16%
Controlled Clinical Trial
16%
Terazosin
16%
Prazosin
16%
Tamsulosin
16%
Silodosin
16%
Alpha 1 Adrenergic Receptor
16%
Alfuzosin
16%